Prior information for population pharmacokinetic and pharmacokinetic/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine

被引:47
作者
Chan Kwong, Anna H. -X. P. [1 ,2 ,3 ,4 ]
Calvier, Elisa A. M. [4 ]
Fabre, David [4 ]
Gattacceca, Florence [3 ]
Khier, Sonia [1 ,2 ]
机构
[1] Montpellier Univ, Sch Pharm, Pharmacokinet & Modeling Dept, Montpellier, France
[2] Montpellier Univ, CNRS, Inst Montpellierain Alexander Grothendiec IMAG, Probabil & Stat Dept,UMR 5149, Montpellier, France
[3] Aix Marseille Univ, CRCM, Inst Paoli Calmettes, SMARTc Grp,Inserm,CNRS, Marseille, France
[4] Sanofi R&D, Translat Med & Early Dev, Pharmacokinet Dynam & Metab PKDM, Montpellier, France
关键词
Population pharmacokinetics; Pharmacokinetic-pharmacodynamic; PRIOR; NONMEM; Guidance; Model; PRIOR DISTRIBUTIONS; MODEL; METABOLITES;
D O I
10.1007/s10928-020-09695-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Population pharmacokinetic analysis is used to estimate pharmacokinetic parameters and their variability from concentration data. Due to data sparseness issues, available datasets often do not allow the estimation of all parameters of the suitable model. The PRIOR subroutine in NONMEM supports the estimation of some or all parameters with values from previous models, as an alternative to fixing them or adding data to the dataset. From a literature review, the best practices were compiled to provide a practical guidance for the use of the PRIOR subroutine in NONMEM. Thirty-three articles reported the use of the PRIOR subroutine in NONMEM, mostly in special populations. This approach allowed fast, stable and satisfying modelling. The guidance provides general advice on how to select the most appropriate reference model when there are several previous models available, and to implement and weight the selected parameter values in the PRIOR function. On the model built with PRIOR, the similarity of estimates with the ones of the reference model and the sensitivity of the model to the PRIOR values should be checked. Covariates could be implemented a priori (from the reference model) or a posteriori, only on parameters estimated without prior (search for new covariates). [GRAPHICS] .
引用
收藏
页码:431 / 446
页数:16
相关论文
共 42 条
[1]   Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV [J].
Abdelwahab, Mahmoud Tareq ;
Leisegang, Rory ;
Dooley, Kelly E. ;
Mathad, Jyoti S. ;
Wiesner, Lubbe ;
McIlleron, Helen ;
Martinson, Neil ;
Waja, Ziyaad ;
Letutu, Matebogo ;
Chaisson, Richard E. ;
Denti, Paolo .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
[2]   Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing [J].
Ali, Ali Mohamed ;
Penny, Melissa A. ;
Smith, Thomas A. ;
Workman, Lesley ;
Sasi, Philip ;
Adjei, George O. ;
Aweeka, Francesca ;
Kiechel, Jean-Rene ;
Jullien, Vincent ;
Rijken, Marcus J. ;
McGready, Rose ;
Mwesigwa, Julia ;
Kristensen, Kim ;
Stepniewska, Kasia ;
Tarning, Joel ;
Barnes, Karen I. ;
Denti, Paolo .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (10)
[3]  
[Anonymous], NPDE FUNCT
[4]   NONMEM Tutorial Part II: Estimation Methods and Advanced Examples [J].
Bauer, Robert J. .
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (08) :538-556
[5]  
Bonate PL, 2011, PHARMACOKINETIC-PHARMACODYNAMIC MODELING AND SIMULATION, SECOND EDITION, P1, DOI 10.1007/978-1-4419-9485-1
[6]   Confirming model-predicted pharmacokinetic interactions between bedaquiline and lopinavir/ritonavir or nevirapine in patients with HIV and drug-resistant tuberculosis [J].
Brill, Margreke J. E. ;
Svensson, Elin M. ;
Pandie, Mishal ;
Maartens, Gary ;
Karlsson, Mats O. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (02) :212-217
[7]   A Model-Based Approach to Dose Selection in Early Pediatric Development [J].
Cella, M. ;
de Vries, F. Gorter ;
Burger, D. ;
Danhof, M. ;
Della Pasqua, O. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (03) :294-302
[8]   Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models [J].
Cella, Massimo ;
Knibbe, Catherijne ;
de Wildt, Saskia N. ;
Van Gerven, Joop ;
Danhof, Meindert ;
Della Pasqua, Oscar .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 74 (03) :525-535
[9]  
Chan Kwong A, 2019, EVALUATION SUITABILI
[10]  
Chan Kwong A, 2019, BRIDGING STUDIES HAN